United Arab Emirates Liquid Biopsy Market to 2032
Overview
The United Arab Emirates Liquid Biopsy Market is expected to reach a 19.68 USD Billion by 2032 and is projected to grow at a CAGR of 15.65% from 2025 to 2032.
Revenue, 2024 (USD Billion)
7.79
Forecast, 2032 (USD Billion)
19.68
CAGR, 2024 - 2032
15.65%
Report Coverage
United Arab Emirates
United Arab Emirates Liquid Biopsy Market 2018-2032 USD Billion
United Arab Emirates Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 7.79 USD Billion
- Projected Market Size (2032): 19.68 USD Billion
- CAGR (2025-2032): 15.65%
Key Findings of United Arab Emirates Liquid Biopsy Market
- The United Arab Emirates Liquid Biopsy Market was valued at 7.79 USD Billion in 2024.
- The United Arab Emirates Liquid Biopsy Market is likely to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Multi-Gene-Parallel Analysis in Technology Segment accounted for the largest share of the market with a revenue of 6.60 USD Billion
- The fastest growing segment Circulating Tumor Cells (CTCS) in Biomaker Segment grew Fastest with a CAGR of 17.61% during the forecast period from 2024 to 2032.
United Arab Emirates Liquid Biopsy Market Scope
United Arab Emirates Liquid Biopsy Market Segmentation & Scope
Application
- Non-Cancer Applications
- Cancer Applications
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Product
- Services & Software
- Instruments
- Consumables & Accessories
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
United Arab Emirates Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 7.79 USD Billion |
| Market Value in 2032 | 19.68 USD Billion |
| CAGR (2025-2032) | 15.65% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Analytical,Clinical Application,Distribution Channel,End User,Technology,Product,Sample,Biomaker |
Regional Insights:
-
Leading Market (2024-2032): United Arab Emirates, leading in terms of revenue 7.79 USD Billion in 2024
- Key Country: United Arab Emirates, leading in terms of revenue with value of 7.79 USD Billion in 2024.
Segments and Scope
-
United Arab Emirates Liquid Biopsy Market to 2032, By Application
- Cancer Applications is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 6.58 USD Billion in the year 2024.
- Cancer Applications is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 15.90 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By Analytical
- Molecular is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 5.50 USD Billion in the year 2024.
- Proteomic is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 16.34 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By Clinical Application
- Routine Screening is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 4.63 USD Billion in the year 2024.
- Routine Screening is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 16.95 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 5.99 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 15.96 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By End User
- Hospitals is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 5.50 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 16.30 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By Technology
- Multi-Gene-Parallel Analysis is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 6.60 USD Billion in the year 2024.
- Multi-Gene-Parallel Analysis is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 15.93 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By Product
- Consumables & Accessories is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 5.29 USD Billion in the year 2024.
- Consumables & Accessories is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 16.39 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By Sample
- Blood Sample-Based is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 5.38 USD Billion in the year 2024.
- Blood Sample-Based is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 16.43 % in forecast period 2025-2032.
-
United Arab Emirates Liquid Biopsy Market to 2032, By Biomaker
- Circulating Tumor Cells (CTCS) is the largest segment in United Arab Emirates Liquid Biopsy Market to 2032 with a revenue of 4.55 USD Billion in the year 2024.
- Circulating Tumor Cells (CTCS) is the Fastest growing segment in United Arab Emirates Liquid Biopsy Market to 2032 with a Growth rate of 17.61 % in forecast period 2025-2032.
United Arab Emirates Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Guardant Health | |||
| Exact Sciences Corporation | |||
| F. Hoffmann-La Roche Ltd. | |||
United Arab Emirates Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
United Arab Emirates Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The United Arab Emirates Liquid Biopsy Market is segmented based on Segmentation Application,Analytical,Clinical Application,Distribution Channel,End User,Technology,Product,Sample,Biomaker.
United Arab Emirates Liquid Biopsy Market was valued at USD 7.79(Revenue in USD Billion) in 2021.
United Arab Emirates Liquid Biopsy Market is projected to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
The Multi-Gene-Parallel Analysis segment is expected to dominate the United Arab Emirates Liquid Biopsy Market, holding a largest market share of 6.60 USD Billion in 2024
United Arab Emirates Liquid Biopsy Market Scope
United Arab Emirates Liquid Biopsy Market Segmentation & Scope
Application
- Non-Cancer Applications
- Cancer Applications
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Technology
- Single Gene Analysis
- Multi-Gene-Parallel Analysis
Product
- Services & Software
- Instruments
- Consumables & Accessories
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Biomaker
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
- Circulating Tumor Cells (CTCS)
Frequently Asked Questions
The United Arab Emirates Liquid Biopsy Market is segmented based on Segmentation Application,Analytical,Clinical Application,Distribution Channel,End User,Technology,Product,Sample,Biomaker.
United Arab Emirates Liquid Biopsy Market was valued at USD 7.79(Revenue in USD Billion) in 2021.
United Arab Emirates Liquid Biopsy Market is projected to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Liquid Biopsy Market for final year is USD 19.68 (USD Billion).
United Arab Emirates Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The United Arab Emirates Liquid Biopsy Market is segmented based on Segmentation Application,Analytical,Clinical Application,Distribution Channel,End User,Technology,Product,Sample,Biomaker.
United Arab Emirates Liquid Biopsy Market was valued at USD 7.79(Revenue in USD Billion) in 2021.
United Arab Emirates Liquid Biopsy Market is projected to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Liquid Biopsy Market for final year is USD 19.68 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.